Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/43203
Title: | Changes in anticancer treatment plans in patients with solid cancer hospitalized with COVID-19: analysis of the nationwide BSMO-COVID registry providing lessons for the future | Authors: | Geukens, T Brandao, M Laenen, A Collignon, J Van Marcke, C Louviaux, I Demey, W Van Wambeke, S Schrijvers, D Lecomte, S MEBIS, Jeroen Fontaine, C Rutten , A Lybaert, W Aspeslagh, S Goeminne, JC Van Den Bulck, H Seront, E De Backer, L De Roock, W Ignatiadis, M Prenen, H Van Beckhoven, D Heijlen, M Verheezen, J Rottey, S Punie, K de Azambuja, E |
Issue Date: | 2022 | Publisher: | ELSEVIERRADARWEG 29 | Source: | ESMO open, 7 (6) (Art N° 100610) | Abstract: | Solid cancer is an independent prognostic factor for poor outcome with COVID-19. As guidelines for patient management in that setting depend on retrospective efforts, we here present the first analyses of a nationwide database of patients with cancer hospitalized with COVID-19 in Belgium, with a focus on changes in anticancer treatment plans at the time of SARS-CoV-2 infection. | Keywords: | COVID-19;cancer;treatment changes;prognosis;solid tumours | Document URI: | http://hdl.handle.net/1942/43203 | ISSN: | 2059-7029 | e-ISSN: | 2059-7029 | DOI: | 10.1016/j.esmoop.2022.100610 | ISI #: | 000903993700014 | Rights: | 2022 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). | Category: | A1 | Type: | Journal Contribution |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Changes in anticancer treatment plans in patients with solid cancer hospitalized with COVID-19_ analysis of the the future.pdf | Published version | 366.03 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.